March 3, 2015 | Teva Pharmaceutical Industries announced that it signed an agreement to sell its Sellersville, Pennsylvania facilities to G&W Laboratories. The sale is part of Teva’s plan to streamline operations by cutting down on manufacturing costs. The sale will include all of the company’s buildings, land and equipment on site, and according to the terms of the agreement G&W will continue to manufacture and supply supplies to Teva, according to its needs. According to the deal, Teva will also sell about 25 portfolio products to G&W, which will be manufactured and sold in the US under the G&W label. Teva Pharmaceutical Industries was founded in 1901 and is headed by CEO and President Erez Vigodman.